Global InjectableDrug Delivery Market, by Device Type (Prefilled Syringes, Autoinjectors,Pens, Conventional Syringes, Cartridges, Ampoules, Vials, and Others), byMaterial Type (Glass and Plastic), by Usability (Disposable and Reusable), byRoute of Administration (Intravenous, Intramuscular, and Subcutaneous), by EndUser (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, andOthers), and by Region (North America, Latin America, Europe, Asia Pacific,Middle East, and Africa) was valued at US$ 15,939.0 million in 2017, and is projected to exhibit a CAGR of 8.3%over the forecast period (2018 – 2026), as highlighted in a new reportpublished by Coherent Market Insights.
Increasing product approval andlaunch by market players to augment the market growth
Key players in the market arefocused on development of product and approval from regulatory authorities, inorder to cater to the demands of patient diagnosed with chronic diseases. Forinstance, in October, 2018, Genentech announced the U.S. Food and DrugAdministration (FDA) approval for single-dose prefilled syringes (PFS) forXolair (omalizumab) as an additional formulation for both allergic asthma andchronic idiopathic urticaria (CIU) indications.
Similarly, in August 2018, a newdiabetes autoinjector pen by AstraZeneca- Bydureon Bcise was approved byEuropean Commission, thereby offering additional treatment options for patientswith type-2 diabetes. Moreover, the market players are focused on increasing productioncapacity and facility launch to expand their offerings and services, which isexpected to boost the market growth. For instance, in March 2019, GerresheimerAG announced to build a new plant at North Macedonia, Europe to producepharmaceutical plastic systems and prefillable syringes for the pharmaceuticalindustry and the medical technology sector. Furthermore, increasing awarenessregarding safety and concern for needlestick injuries is a major factor drivingthe global injectable drug delivery market.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2768
According to the HealthProtection Agency (HPA) report in 2012, injuries among medical and dentalprofessionals while treating patients increased by 131% (100-231) from 2002 to2011.
Browse 38 Market Data Tables and32 Figures spread through 262 Pages and in-depth TOC on ‘Injectable DrugDelivery Market’- Global Forecast to 2026, by Device Type (Prefilled Syringes,Auto Injectors, Pens, Conventional Syringes, Cartridges, Ampoules, Vials, andOthers), by Material Type (Glass and Plastic), by Usability (Disposable andReusable), by Route of Administration (Intravenous, Intramuscular, andSubcutaneous), by End User (Hospitals, Clinics, Ambulatory Surgical Centers,Home Care Settings, and Others), and by Region (North America, Latin America,Europe, Asia Pacific, Middle East, and Africa)
Key players in the market arefocused on adopting strategies such as collaborations and acquisitions toenhance their service offerings. For instance, in December 2016, SMC Ltd.acquired Oval Medical Technologies Ltd. to expand its drug deliverycapabilities and product offerings to pharmaceutical manufacturers. Similarly,in December 2017, Numedico Technologies signed an agreement with Mana MedicalServices. According to agreement, the latter will distribute ClickZip NeedleRetractable Safety Syringe in New Zealand and Australia.
Key Takeaways of the GlobalInjectable Drug Delivery Market:
The global injectable drugdelivery market is expected to exhibit a CAGR of 8.3% over the forecast period,owing to the product launch by the market players. For instance, in 2018,AbbVie GK and Eisai Co., Ltd. launched an autoinjection delivery system forHUMIRA for Subcutaneous Injection 40 mg Pen 0.4 mL and 80 mg Pen 0.8 mL.
Browse ResearchReport: https://www.coherentmarketinsights.com/market-insight/injectable-drug-delivery-market-2768
Among material type, the plasticsegment held a dominant position in the global injectable drug delivery marketin 2018, owing to launch of plastic syringes and cartridges. For instance, inJune 2016, Gerresheimer launched Gx RTF ClearJect, a prefillable plasticsyringe with integrated cannula, which is made from high-performance cycloolefin polymer (COP) plastic for sensitive medications and high-viscosityagents.
Among usability, the disposablesegment held dominant position in the global injectable drug delivery market in2018, owing to significant increase in self-administration to treat chronicdiseases
Among route of administration,the subcutaneous segment held a dominant position in the global injectable drugdelivery market in 2018, as pens and auto-injectors are mainly used forsubcutaneous delivery of biopharmaceuticals, mainly for self-administrating
Among end user type, homecaresettings segment held a dominant position in the globl injectable drug deliverymarket in 2018, owing to cost-effective and reliable home-based care fortreating chronic conditions
Key players operating in theglobal injectable drug delivery market include, Becton, Dickinson and Company,Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, TerumoCorporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen MumfordLimited, Injex Pharma GmbH
Buy-Now researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2768
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200 Seattle,WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
